According to our (Global Info Research) latest study, the global Erectile Dysfunction Oral Medications market size was valued at US$ 143 million in 2024 and is forecast to a readjusted size of USD 182 million by 2031 with a CAGR of 3.5% during review period.
Sildenafil (Viagra), vardenafil (Levitra, Staxyn), tadalafil (Cialis) and avanafil (Stendra) are oral medications that reverse erectile dysfunction by enhancing the effects of nitric oxide, a natural chemical your body produces that relaxes muscles in the penis.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report is a detailed and comprehensive analysis for global Erectile Dysfunction Oral Medications market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Erectile Dysfunction Oral Medications market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Erectile Dysfunction Oral Medications market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Erectile Dysfunction Oral Medications market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Erectile Dysfunction Oral Medications market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Erectile Dysfunction Oral Medications
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Erectile Dysfunction Oral Medications market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Eli Lilly, Pfizer, Bayer, S.K. Chemicals, Teva Pharma, Dong-A ST, Petros Pharmaceuticals, Seoul Pharma, BaiYunShan General Factory, Yabang Pharmacy, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Erectile Dysfunction Oral Medications market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Sildenafil
Tadalafil
Others
Market segment by Application
Hospital Pharmacies
Private Clinics
Retail Pharmacies
E-Commerce
Major players covered
Eli Lilly
Pfizer
Bayer
S.K. Chemicals
Teva Pharma
Dong-A ST
Petros Pharmaceuticals
Seoul Pharma
BaiYunShan General Factory
Yabang Pharmacy
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Erectile Dysfunction Oral Medications product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Erectile Dysfunction Oral Medications, with price, sales quantity, revenue, and global market share of Erectile Dysfunction Oral Medications from 2020 to 2025.
Chapter 3, the Erectile Dysfunction Oral Medications competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Erectile Dysfunction Oral Medications breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Erectile Dysfunction Oral Medications market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Erectile Dysfunction Oral Medications.
Chapter 14 and 15, to describe Erectile Dysfunction Oral Medications sales channel, distributors, customers, research findings and conclusion.
- 1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Market Analysis by Type
- 1.3.1 Overview: Global Erectile Dysfunction Oral Medications Consumption Value by Type: 2020 Versus 2024 Versus 2031
- 1.3.2 Sildenafil
- 1.3.3 Tadalafil
- 1.3.4 Others
- 1.4 Market Analysis by Application
- 1.4.1 Overview: Global Erectile Dysfunction Oral Medications Consumption Value by Application: 2020 Versus 2024 Versus 2031
- 1.4.2 Hospital Pharmacies
- 1.4.3 Private Clinics
- 1.4.4 Retail Pharmacies
- 1.4.5 E-Commerce
- 1.5 Global Erectile Dysfunction Oral Medications Market Size & Forecast
- 1.5.1 Global Erectile Dysfunction Oral Medications Consumption Value (2020 & 2024 & 2031)
- 1.5.2 Global Erectile Dysfunction Oral Medications Sales Quantity (2020-2031)
- 1.5.3 Global Erectile Dysfunction Oral Medications Average Price (2020-2031)
- 2 Manufacturers Profiles
- 2.1 Eli Lilly
- 2.1.1 Eli Lilly Details
- 2.1.2 Eli Lilly Major Business
- 2.1.3 Eli Lilly Erectile Dysfunction Oral Medications Product and Services
- 2.1.4 Eli Lilly Erectile Dysfunction Oral Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.1.5 Eli Lilly Recent Developments/Updates
- 2.2 Pfizer
- 2.2.1 Pfizer Details
- 2.2.2 Pfizer Major Business
- 2.2.3 Pfizer Erectile Dysfunction Oral Medications Product and Services
- 2.2.4 Pfizer Erectile Dysfunction Oral Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.2.5 Pfizer Recent Developments/Updates
- 2.3 Bayer
- 2.3.1 Bayer Details
- 2.3.2 Bayer Major Business
- 2.3.3 Bayer Erectile Dysfunction Oral Medications Product and Services
- 2.3.4 Bayer Erectile Dysfunction Oral Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.3.5 Bayer Recent Developments/Updates
- 2.4 S.K. Chemicals
- 2.4.1 S.K. Chemicals Details
- 2.4.2 S.K. Chemicals Major Business
- 2.4.3 S.K. Chemicals Erectile Dysfunction Oral Medications Product and Services
- 2.4.4 S.K. Chemicals Erectile Dysfunction Oral Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.4.5 S.K. Chemicals Recent Developments/Updates
- 2.5 Teva Pharma
- 2.5.1 Teva Pharma Details
- 2.5.2 Teva Pharma Major Business
- 2.5.3 Teva Pharma Erectile Dysfunction Oral Medications Product and Services
- 2.5.4 Teva Pharma Erectile Dysfunction Oral Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.5.5 Teva Pharma Recent Developments/Updates
- 2.6 Dong-A ST
- 2.6.1 Dong-A ST Details
- 2.6.2 Dong-A ST Major Business
- 2.6.3 Dong-A ST Erectile Dysfunction Oral Medications Product and Services
- 2.6.4 Dong-A ST Erectile Dysfunction Oral Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.6.5 Dong-A ST Recent Developments/Updates
- 2.7 Petros Pharmaceuticals
- 2.7.1 Petros Pharmaceuticals Details
- 2.7.2 Petros Pharmaceuticals Major Business
- 2.7.3 Petros Pharmaceuticals Erectile Dysfunction Oral Medications Product and Services
- 2.7.4 Petros Pharmaceuticals Erectile Dysfunction Oral Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.7.5 Petros Pharmaceuticals Recent Developments/Updates
- 2.8 Seoul Pharma
- 2.8.1 Seoul Pharma Details
- 2.8.2 Seoul Pharma Major Business
- 2.8.3 Seoul Pharma Erectile Dysfunction Oral Medications Product and Services
- 2.8.4 Seoul Pharma Erectile Dysfunction Oral Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.8.5 Seoul Pharma Recent Developments/Updates
- 2.9 BaiYunShan General Factory
- 2.9.1 BaiYunShan General Factory Details
- 2.9.2 BaiYunShan General Factory Major Business
- 2.9.3 BaiYunShan General Factory Erectile Dysfunction Oral Medications Product and Services
- 2.9.4 BaiYunShan General Factory Erectile Dysfunction Oral Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.9.5 BaiYunShan General Factory Recent Developments/Updates
- 2.10 Yabang Pharmacy
- 2.10.1 Yabang Pharmacy Details
- 2.10.2 Yabang Pharmacy Major Business
- 2.10.3 Yabang Pharmacy Erectile Dysfunction Oral Medications Product and Services
- 2.10.4 Yabang Pharmacy Erectile Dysfunction Oral Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.10.5 Yabang Pharmacy Recent Developments/Updates
- 3 Competitive Environment: Erectile Dysfunction Oral Medications by Manufacturer
- 3.1 Global Erectile Dysfunction Oral Medications Sales Quantity by Manufacturer (2020-2025)
- 3.2 Global Erectile Dysfunction Oral Medications Revenue by Manufacturer (2020-2025)
- 3.3 Global Erectile Dysfunction Oral Medications Average Price by Manufacturer (2020-2025)
- 3.4 Market Share Analysis (2024)
- 3.4.1 Producer Shipments of Erectile Dysfunction Oral Medications by Manufacturer Revenue ($MM) and Market Share (%): 2024
- 3.4.2 Top 3 Erectile Dysfunction Oral Medications Manufacturer Market Share in 2024
- 3.4.3 Top 6 Erectile Dysfunction Oral Medications Manufacturer Market Share in 2024
- 3.5 Erectile Dysfunction Oral Medications Market: Overall Company Footprint Analysis
- 3.5.1 Erectile Dysfunction Oral Medications Market: Region Footprint
- 3.5.2 Erectile Dysfunction Oral Medications Market: Company Product Type Footprint
- 3.5.3 Erectile Dysfunction Oral Medications Market: Company Product Application Footprint
- 3.6 New Market Entrants and Barriers to Market Entry
- 3.7 Mergers, Acquisition, Agreements, and Collaborations
- 4 Consumption Analysis by Region
- 4.1 Global Erectile Dysfunction Oral Medications Market Size by Region
- 4.1.1 Global Erectile Dysfunction Oral Medications Sales Quantity by Region (2020-2031)
- 4.1.2 Global Erectile Dysfunction Oral Medications Consumption Value by Region (2020-2031)
- 4.1.3 Global Erectile Dysfunction Oral Medications Average Price by Region (2020-2031)
- 4.2 North America Erectile Dysfunction Oral Medications Consumption Value (2020-2031)
- 4.3 Europe Erectile Dysfunction Oral Medications Consumption Value (2020-2031)
- 4.4 Asia-Pacific Erectile Dysfunction Oral Medications Consumption Value (2020-2031)
- 4.5 South America Erectile Dysfunction Oral Medications Consumption Value (2020-2031)
- 4.6 Middle East & Africa Erectile Dysfunction Oral Medications Consumption Value (2020-2031)
- 5 Market Segment by Type
- 5.1 Global Erectile Dysfunction Oral Medications Sales Quantity by Type (2020-2031)
- 5.2 Global Erectile Dysfunction Oral Medications Consumption Value by Type (2020-2031)
- 5.3 Global Erectile Dysfunction Oral Medications Average Price by Type (2020-2031)
- 6 Market Segment by Application
- 6.1 Global Erectile Dysfunction Oral Medications Sales Quantity by Application (2020-2031)
- 6.2 Global Erectile Dysfunction Oral Medications Consumption Value by Application (2020-2031)
- 6.3 Global Erectile Dysfunction Oral Medications Average Price by Application (2020-2031)
- 7 North America
- 7.1 North America Erectile Dysfunction Oral Medications Sales Quantity by Type (2020-2031)
- 7.2 North America Erectile Dysfunction Oral Medications Sales Quantity by Application (2020-2031)
- 7.3 North America Erectile Dysfunction Oral Medications Market Size by Country
- 7.3.1 North America Erectile Dysfunction Oral Medications Sales Quantity by Country (2020-2031)
- 7.3.2 North America Erectile Dysfunction Oral Medications Consumption Value by Country (2020-2031)
- 7.3.3 United States Market Size and Forecast (2020-2031)
- 7.3.4 Canada Market Size and Forecast (2020-2031)
- 7.3.5 Mexico Market Size and Forecast (2020-2031)
- 8 Europe
- 8.1 Europe Erectile Dysfunction Oral Medications Sales Quantity by Type (2020-2031)
- 8.2 Europe Erectile Dysfunction Oral Medications Sales Quantity by Application (2020-2031)
- 8.3 Europe Erectile Dysfunction Oral Medications Market Size by Country
- 8.3.1 Europe Erectile Dysfunction Oral Medications Sales Quantity by Country (2020-2031)
- 8.3.2 Europe Erectile Dysfunction Oral Medications Consumption Value by Country (2020-2031)
- 8.3.3 Germany Market Size and Forecast (2020-2031)
- 8.3.4 France Market Size and Forecast (2020-2031)
- 8.3.5 United Kingdom Market Size and Forecast (2020-2031)
- 8.3.6 Russia Market Size and Forecast (2020-2031)
- 8.3.7 Italy Market Size and Forecast (2020-2031)
- 9 Asia-Pacific
- 9.1 Asia-Pacific Erectile Dysfunction Oral Medications Sales Quantity by Type (2020-2031)
- 9.2 Asia-Pacific Erectile Dysfunction Oral Medications Sales Quantity by Application (2020-2031)
- 9.3 Asia-Pacific Erectile Dysfunction Oral Medications Market Size by Region
- 9.3.1 Asia-Pacific Erectile Dysfunction Oral Medications Sales Quantity by Region (2020-2031)
- 9.3.2 Asia-Pacific Erectile Dysfunction Oral Medications Consumption Value by Region (2020-2031)
- 9.3.3 China Market Size and Forecast (2020-2031)
- 9.3.4 Japan Market Size and Forecast (2020-2031)
- 9.3.5 South Korea Market Size and Forecast (2020-2031)
- 9.3.6 India Market Size and Forecast (2020-2031)
- 9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
- 9.3.8 Australia Market Size and Forecast (2020-2031)
- 10 South America
- 10.1 South America Erectile Dysfunction Oral Medications Sales Quantity by Type (2020-2031)
- 10.2 South America Erectile Dysfunction Oral Medications Sales Quantity by Application (2020-2031)
- 10.3 South America Erectile Dysfunction Oral Medications Market Size by Country
- 10.3.1 South America Erectile Dysfunction Oral Medications Sales Quantity by Country (2020-2031)
- 10.3.2 South America Erectile Dysfunction Oral Medications Consumption Value by Country (2020-2031)
- 10.3.3 Brazil Market Size and Forecast (2020-2031)
- 10.3.4 Argentina Market Size and Forecast (2020-2031)
- 11 Middle East & Africa
- 11.1 Middle East & Africa Erectile Dysfunction Oral Medications Sales Quantity by Type (2020-2031)
- 11.2 Middle East & Africa Erectile Dysfunction Oral Medications Sales Quantity by Application (2020-2031)
- 11.3 Middle East & Africa Erectile Dysfunction Oral Medications Market Size by Country
- 11.3.1 Middle East & Africa Erectile Dysfunction Oral Medications Sales Quantity by Country (2020-2031)
- 11.3.2 Middle East & Africa Erectile Dysfunction Oral Medications Consumption Value by Country (2020-2031)
- 11.3.3 Turkey Market Size and Forecast (2020-2031)
- 11.3.4 Egypt Market Size and Forecast (2020-2031)
- 11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
- 11.3.6 South Africa Market Size and Forecast (2020-2031)
- 12 Market Dynamics
- 12.1 Erectile Dysfunction Oral Medications Market Drivers
- 12.2 Erectile Dysfunction Oral Medications Market Restraints
- 12.3 Erectile Dysfunction Oral Medications Trends Analysis
- 12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry
- 13 Raw Material and Industry Chain
- 13.1 Raw Material of Erectile Dysfunction Oral Medications and Key Manufacturers
- 13.2 Manufacturing Costs Percentage of Erectile Dysfunction Oral Medications
- 13.3 Erectile Dysfunction Oral Medications Production Process
- 13.4 Industry Value Chain Analysis
- 14 Shipments by Distribution Channel
- 14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
- 14.2 Erectile Dysfunction Oral Medications Typical Distributors
- 14.3 Erectile Dysfunction Oral Medications Typical Customers
- 15 Research Findings and Conclusion
- 16 Appendix
- 16.1 Methodology
- 16.2 Research Process and Data Source
- 16.3 Disclaimer
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook